1 / 3

Human Growth Hormone Market – Size, Share, Outlook and Opportunity Analysis,Trends,Growth,share,size 2018-2026

Human body naturally produces growth hormones in the pituitary gland. Human growth hormone is a peptide hormone, which stimulates growth, cell reproduction, and cell regeneration in humans as well as animals.

RUSHIKESH
Télécharger la présentation

Human Growth Hormone Market – Size, Share, Outlook and Opportunity Analysis,Trends,Growth,share,size 2018-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Human Growth Hormone Market – Size, Share, Outlook and Opportunity Analysis,Trends,Growth,share,size 2018-2026 Human Growth Hormone Market, By Application , By Route of Administration , By Distribution Channel , and By Region – Size, Share, Outlook, and Opportunity Analysis, 2018-202 Human Growth Hormone Market Human body naturally produces growth hormones in the pituitary gland. Human growth hormone is a peptide hormone, which stimulates growth, cell reproduction, and cell regeneration in humans as well as animals. Growth hormone is stored and secreted by somatotropic cells within the lateral wings of anterior pituitary gland. Functions of growth hormones include increased height during childhood, increases calcium retention, strengthens and increases mineralization of the bone, increases muscle mass through sarcomere hypertrophy, promotes lipolysis, increases protein synthesis, stimulates growth of all internal organs excluding the brain, plays a vital role in homeostasis, reduces uptake of glucose by liver, stimulates the immune system, and increases DE iodination of T4 to T3. Excess secretion of growth hormones causes pituitary tumor, which consists of somatotroph cells of the anterior pituitary. These somatotroph cells are benign and grow slowly, producing excess of growth hormones. This causes headaches, impaired vision by pressure caused on optic nerves, defciency of other hormones secreted by pituitary gland, and thickening the bones of jaw, toes, and fngers, which eventually results in heaviness of jaws and increase in size of digits called as acromegaly. Acromegaly causes pressure on nerves, muscle weakness, and reduced sexual function. The defciency of

  2. growth hormone causes failure in growth, increase in osteoclast activities, weakening of bones, trauma, increase in fat mass, and decrease in muscle mass. Download PDF Brochure of Market Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1859 Human Growth Hormone Market Regional Analysis:- North America is expected to hold dominant position in the global human growth hormone market due to new biosimilar approvals by Health Canada for biosimilar of human growth hormone drugs. For instance, in 2015, Health Canada approved the frst generic biological called as PROmnitrope. PROmnitrope is a recombinant human growth hormone used to treat defciency of growth hormone in adults as well as children. This can encourage new generic version of drugs, thereby fueling the human growth hormone market growth. Europe human growth hormone market is expected to witness signifcant growth due to mergers and acquisitions. For instance, in 2017, Ferring Pharmaceuticals S.A., a pharmaceutical company, acquired a product i.e. Zoma Jet of Antares Pharma Inc, a pharmaceutical company. Zoma Jet is a needle free auto injectable device. Ferring Pharmaceuticals S.A acquired Zoma Jet in order to increase use of Zomacton (Injectable somatropin hGH). Zoma Jet is used to deliver Zomacton for the treatment of growth hormone defciency in children and Turner’s syndrome in girls. By acquiring the injectable device Zoma Jet, would eventually lead to increase in use of the drug, Zomacton, which will further encourage Ferring Pharmaceuticals to develop better treatment options for growth hormone defciency, thereby resulting in growth of the human growth hormone market. Asia Pacifc is expected to grow over the forecast period due to robust pipeline. For instance, Cinna Tropin sponsored by Cinnagen, an Iran-based company, completed phase 3 clinical trials in 2017. This drug is used to treat idiopathic short stature in children and adults.

  3. Browse more about the Deep Brain Stimulation Devices Market Study: https://www.coherentmarketinsights.com/insight/request-customization/1859 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting frm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: sales@coherentmarketinsights.com

More Related